These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17510114)
21. A policy of no pharmaceutical industry sponsorship: a case for health equity. Pinhao Chao P N Z Med J; 2011 Oct; 124(1344):115-6. PubMed ID: 22016176 [No Abstract] [Full Text] [Related]
22. Medicine and the pharmaceutical industry: a call to action. Stiles MM; Barrett B Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137 [No Abstract] [Full Text] [Related]
23. New Zealand doctors and the pharmaceutical industry--time to cut the cord? Menkes DB N Z Med J; 2011 Aug; 124(1341):6-8. PubMed ID: 21959629 [No Abstract] [Full Text] [Related]
24. The pharmaceutical industry has a contribution to make to evidence-based healthcare. Sheehy K N Z Med J; 2012 Jan; 125(1348):110-1. PubMed ID: 22282289 [No Abstract] [Full Text] [Related]
25. Doctors and drug companies. Lambert LA N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575 [No Abstract] [Full Text] [Related]
27. Lunch with Lilly: who pays? Strong C Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499 [No Abstract] [Full Text] [Related]
28. Banning pharmaceutical sponsorship: is ethical apartheid the right road ahead? Gravatt L N Z Med J; 2011 Nov; 124(1345):96-7. PubMed ID: 22072176 [No Abstract] [Full Text] [Related]
29. Cheap trinkets, effective marketing: small gifts from drug companies to physicians. Brett AS Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493 [No Abstract] [Full Text] [Related]
30. Banning pens and pads misses the main point. Terry SF; Burke W Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500 [No Abstract] [Full Text] [Related]
31. Medical students protest perks from drug companies. Opar A Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192 [No Abstract] [Full Text] [Related]
32. Drug representatives: giving you lunch or stealing your soul? Higgins SP Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002 [TBL] [Abstract][Full Text] [Related]
33. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine. Krimsky S Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492 [No Abstract] [Full Text] [Related]
34. Relationships between the pharmaceutical industry and patients' organisations. Herxheimer A BMJ; 2003 May; 326(7400):1208-10. PubMed ID: 12775627 [TBL] [Abstract][Full Text] [Related]
35. Prohibiting gifts from industry representatives: a case study. Amdur RJ Am J Clin Oncol; 2009 Feb; 32(1):94-8. PubMed ID: 19194134 [No Abstract] [Full Text] [Related]
36. Spanish doctors say "no thank you" to drug industry gifts. Jara M BMJ; 2008 Sep; 337():a1579. PubMed ID: 18779223 [No Abstract] [Full Text] [Related]
37. Large or small, a gift is a gift is a gift. Paris JJ Am J Bioeth; 2003; 3(3):W30. PubMed ID: 14594482 [No Abstract] [Full Text] [Related]
38. Relationships between medical students and drug companies in New Zealand. Wyber R; Fancourt N; Stone B N Z Med J; 2011 Aug; 124(1341):58-64. PubMed ID: 21959637 [TBL] [Abstract][Full Text] [Related]
39. [Is it pertinent to investigate the relations between physicians and the drug industry]. Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930 [TBL] [Abstract][Full Text] [Related]